UniProt ID | KCC4_HUMAN | |
---|---|---|
UniProt AC | Q16566 | |
Protein Name | Calcium/calmodulin-dependent protein kinase type IV | |
Gene Name | CAMK4 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 473 | |
Subcellular Localization | Cytoplasm. Nucleus. Localized in hippocampal neuron nuclei. In spermatids, associated with chromatin and nuclear matrix (By similarity).. | |
Protein Description | Calcium/calmodulin-dependent protein kinase that operates in the calcium-triggered CaMKK-CaMK4 signaling cascade and regulates, mainly by phosphorylation, the activity of several transcription activators, such as CREB1, MEF2D, JUN and RORA, which play pivotal roles in immune response, inflammation, and memory consolidation. In the thymus, regulates the CD4(+)/CD8(+) double positive thymocytes selection threshold during T-cell ontogeny. In CD4 memory T-cells, is required to link T-cell antigen receptor (TCR) signaling to the production of IL2, IFNG and IL4 (through the regulation of CREB and MEF2). Regulates the differentiation and survival phases of osteoclasts and dendritic cells (DCs). Mediates DCs survival by linking TLR4 and the regulation of temporal expression of BCL2. Phosphorylates the transcription activator CREB1 on 'Ser-133' in hippocampal neuron nuclei and contribute to memory consolidation and long term potentiation (LTP) in the hippocampus. Can activate the MAP kinases MAPK1/ERK2, MAPK8/JNK1 and MAPK14/p38 and stimulate transcription through the phosphorylation of ELK1 and ATF2. Can also phosphorylate in vitro CREBBP, PRM2, MEF2A and STMN1/OP18.. | |
Protein Sequence | MLKVTVPSCSASSCSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAANFVHMDTAQKKLQEFNARRKLKAAVKAVVASSRLGSASSSHGSIQESHKASRDPSPIQDGNEDMKAIPEGEKIQGDGAQAAVKGAQAELMKVQALEKVKGADINAEEAPKMVPKAVEDGIKVADLELEEGLAEEKLKTVEEAAAPREGQGSSAVGFEVPQQDVILPEY | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
12 | Phosphorylation | TVPSCSASSCSSVTA ECCCCCHHHCCCCEE | 18.64 | 22817900 | |
13 | Phosphorylation | VPSCSASSCSSVTAS CCCCCHHHCCCCEEC | 20.10 | 22817900 | |
32 | Phosphorylation | TASLVPDYWIDGSNR CCCCCCCEEECCCCC | 9.74 | - | |
43 | Phosphorylation | GSNRDALSDFFEVES CCCCHHHHHHHHHHH | 33.81 | 27732954 | |
50 | Phosphorylation | SDFFEVESELGRGAT HHHHHHHHHHCCCCE | 43.21 | - | |
57 | O-linked_Glycosylation | SELGRGATSIVYRCK HHHCCCCEEHEEECC | 23.08 | 19506079 | |
57 | Phosphorylation | SELGRGATSIVYRCK HHHCCCCEEHEEECC | 23.08 | - | |
58 | O-linked_Glycosylation | ELGRGATSIVYRCKQ HHCCCCEEHEEECCC | 14.99 | 19506079 | |
66 | Ubiquitination | IVYRCKQKGTQKPYA HEEECCCCCCCCCCH | 49.79 | 29967540 | |
70 | Ubiquitination | CKQKGTQKPYALKVL CCCCCCCCCCHHHHH | 39.57 | 29967540 | |
75 | Ubiquitination | TQKPYALKVLKKTVD CCCCCHHHHHHHHCC | 37.03 | 29967540 | |
82 | Ubiquitination | KVLKKTVDKKIVRTE HHHHHHCCHHHHHHH | 52.33 | 29967540 | |
89 | Ubiquitination | DKKIVRTEIGVLLRL CHHHHHHHHHHHHHC | 27.47 | 24816145 | |
106 | Ubiquitination | PNIIKLKEIFETPTE CCEEEHHHHHCCCCH | 64.45 | 29967540 | |
119 | Ubiquitination | TEISLVLELVTGGEL CHHHHEEEHHHCCHH | 33.44 | 29967540 | |
133 | Ubiquitination | LFDRIVEKGYYSERD HHHHHHHCCCCCHHH | 41.12 | - | |
134 | Ubiquitination | FDRIVEKGYYSERDA HHHHHHCCCCCHHHH | 17.07 | 29967540 | |
137 | O-linked_Glycosylation | IVEKGYYSERDAADA HHHCCCCCHHHHHHH | 20.06 | 19506079 | |
157 | Ubiquitination | EAVAYLHENGIVHRD HHHHHHHHCCCCCCC | 55.33 | 29967540 | |
166 | Ubiquitination | GIVHRDLKPENLLYA CCCCCCCCHHHCEEC | 55.35 | 30230243 | |
172 | Phosphorylation | LKPENLLYATPAPDA CCHHHCEECCCCCCC | 16.17 | 27642862 | |
182 | Ubiquitination | PAPDAPLKIADFGLS CCCCCCCEEHHCCHH | 34.49 | 29967540 | |
189 | Phosphorylation | KIADFGLSKIVEHQV EEHHCCHHHHHHCHH | 22.25 | 19506079 | |
189 | O-linked_Glycosylation | KIADFGLSKIVEHQV EEHHCCHHHHHHCHH | 22.25 | 19506079 | |
190 | Acetylation | IADFGLSKIVEHQVL EHHCCHHHHHHCHHH | 56.67 | 19608861 | |
190 | Ubiquitination | IADFGLSKIVEHQVL EHHCCHHHHHHCHHH | 56.67 | 19608861 | |
198 | Sulfoxidation | IVEHQVLMKTVCGTP HHHCHHHHHHHCCCC | 3.43 | 21406390 | |
199 | Ubiquitination | VEHQVLMKTVCGTPG HHCHHHHHHHCCCCC | 33.38 | - | |
200 | Phosphorylation | EHQVLMKTVCGTPGY HCHHHHHHHCCCCCC | 13.68 | 8621423 | |
204 | Phosphorylation | LMKTVCGTPGYCAPE HHHHHCCCCCCCHHH | 14.38 | 24117733 | |
207 | Phosphorylation | TVCGTPGYCAPEILR HHCCCCCCCHHHHHC | 6.14 | 29978859 | |
243 | Ubiquitination | CGFEPFYDERGDQFM HCCCCCCCCCCCHHH | 39.22 | 29967540 | |
245 | Ubiquitination | FEPFYDERGDQFMFR CCCCCCCCCCHHHHH | 51.60 | 29967540 | |
250 | Sulfoxidation | DERGDQFMFRRILNC CCCCCHHHHHHHHCC | 1.81 | 21406390 | |
279 | Ubiquitination | NAKDLVRKLIVLDPK CHHHHHHHHHHCCHH | 34.78 | 29967540 | |
286 | Ubiquitination | KLIVLDPKKRLTTFQ HHHHCCHHHCCCHHH | 50.63 | 24816145 | |
303 | Ubiquitination | QHPWVTGKAANFVHM CCCCHHCCHHCCCCC | 34.65 | 29967540 | |
310 | Sulfoxidation | KAANFVHMDTAQKKL CHHCCCCCHHHHHHH | 4.04 | 21406390 | |
315 | Acetylation | VHMDTAQKKLQEFNA CCCHHHHHHHHHHHH | 53.65 | 25953088 | |
316 | Ubiquitination | HMDTAQKKLQEFNAR CCHHHHHHHHHHHHH | 43.24 | 29967540 | |
331 | Ubiquitination | RKLKAAVKAVVASSR HHHHHHHHHHHHHCC | 30.64 | 29967540 | |
331 | Acetylation | RKLKAAVKAVVASSR HHHHHHHHHHHHHCC | 30.64 | 25953088 | |
336 | Phosphorylation | AVKAVVASSRLGSAS HHHHHHHHCCCCCCC | 12.37 | - | |
341 | Phosphorylation | VASSRLGSASSSHGS HHHCCCCCCCCCCCC | 29.57 | 21712546 | |
343 | Phosphorylation | SSRLGSASSSHGSIQ HCCCCCCCCCCCCCC | 33.79 | 28348404 | |
344 | Phosphorylation | SRLGSASSSHGSIQE CCCCCCCCCCCCCCH | 26.52 | 28348404 | |
344 | O-linked_Glycosylation | SRLGSASSSHGSIQE CCCCCCCCCCCCCCH | 26.52 | 19506079 | |
345 | Phosphorylation | RLGSASSSHGSIQES CCCCCCCCCCCCCHH | 29.40 | 19506079 | |
345 | O-linked_Glycosylation | RLGSASSSHGSIQES CCCCCCCCCCCCCHH | 29.40 | 19506079 | |
348 | Phosphorylation | SASSSHGSIQESHKA CCCCCCCCCCHHHHC | 18.70 | 30576142 | |
352 | Phosphorylation | SHGSIQESHKASRDP CCCCCCHHHHCCCCC | 17.57 | 30177828 | |
354 | Acetylation | GSIQESHKASRDPSP CCCCHHHHCCCCCCC | 58.29 | 25953088 | |
354 | Ubiquitination | GSIQESHKASRDPSP CCCCHHHHCCCCCCC | 58.29 | 19413330 | |
356 | O-linked_Glycosylation | IQESHKASRDPSPIQ CCHHHHCCCCCCCCC | 41.86 | 19506079 | |
356 | Phosphorylation | IQESHKASRDPSPIQ CCHHHHCCCCCCCCC | 41.86 | 19413330 | |
360 | Phosphorylation | HKASRDPSPIQDGNE HHCCCCCCCCCCCCC | 38.64 | 23401153 | |
369 | Sulfoxidation | IQDGNEDMKAIPEGE CCCCCCCCCCCCCCC | 2.29 | 21406390 | |
377 | Acetylation | KAIPEGEKIQGDGAQ CCCCCCCCCCCCHHH | 51.70 | 25953088 | |
404 | Ubiquitination | VQALEKVKGADINAE HHHHHHHHCCCCCHH | 60.49 | - | |
440 | Ubiquitination | EEGLAEEKLKTVEEA CCCCHHHHHHHHHHH | 46.95 | 29967540 | |
442 | Ubiquitination | GLAEEKLKTVEEAAA CCHHHHHHHHHHHHC | 62.69 | 29967540 | |
456 | Phosphorylation | APREGQGSSAVGFEV CCCCCCCCCCCCCCC | 13.77 | 26074081 | |
457 | Phosphorylation | PREGQGSSAVGFEVP CCCCCCCCCCCCCCC | 33.52 | 26074081 | |
473 | Phosphorylation | QDVILPEY------- CCCCCCCC------- | 23.16 | 26074081 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
12 | S | Phosphorylation | Kinase | CAMK4 | Q16566 | GPS |
12 | S | Phosphorylation | Kinase | CAMKK1 | Q8N5S9 | PSP |
13 | S | Phosphorylation | Kinase | CAMK4 | Q16566 | GPS |
13 | S | Phosphorylation | Kinase | CAMKK1 | Q8N5S9 | PSP |
200 | T | Phosphorylation | Kinase | KCC1A | Q14012 | PhosphoELM |
200 | T | Phosphorylation | Kinase | CAMKK1 | Q8N5S9 | Uniprot |
200 | T | Phosphorylation | Kinase | CAMKK2 | Q96RR4 | Uniprot |
200 | T | Phosphorylation | Kinase | CAMK1-FAMILY | - | GPS |
336 | S | Phosphorylation | Kinase | CAMK4 | Q16566 | GPS |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of KCC4_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
HDAC4_HUMAN | HDAC4 | physical | 11470791 | |
CABIN_HUMAN | CABIN1 | physical | 15902271 | |
NOTC1_HUMAN | NOTCH1 | physical | 23103515 | |
GIT1_HUMAN | GIT1 | physical | 28514442 | |
ARHG7_HUMAN | ARHGEF7 | physical | 28514442 | |
GIT2_HUMAN | GIT2 | physical | 28514442 | |
ANR28_HUMAN | ANKRD28 | physical | 28514442 | |
PP6R2_HUMAN | PPP6R2 | physical | 28514442 | |
ANR52_HUMAN | ANKRD52 | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-190, AND MASS SPECTROMETRY. | |
O-linked Glycosylation | |
Reference | PubMed |
"Regulation of calcium/calmodulin-dependent kinase IV by O-GlcNAcmodification."; Dias W.B., Cheung W.D., Wang Z., Hart G.W.; J. Biol. Chem. 284:21327-21337(2009). Cited for: GLYCOSYLATION AT THR-57 SER-58; SER-137; SER-189; SER-344; SER-345 ANDSER-356, PHOSPHORYLATION AT THR-200, IDENTIFICATION BY MASSSPECTROMETRY, AND MUTAGENESIS OF 57-THR-SER-58 AND SER-189. | |
Phosphorylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-356 AND SER-360, ANDMASS SPECTROMETRY. | |
"Proteomics analysis of protein kinases by target class-selectiveprefractionation and tandem mass spectrometry."; Wissing J., Jaensch L., Nimtz M., Dieterich G., Hornberger R.,Keri G., Wehland J., Daub H.; Mol. Cell. Proteomics 6:537-547(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-341 AND SER-360, ANDMASS SPECTROMETRY. | |
"A unique phosphorylation-dependent mechanism for the activation ofCa2+/calmodulin-dependent protein kinase type IV/GR."; Chatila T., Anderson K.A., Ho N., Means A.R.; J. Biol. Chem. 271:21542-21548(1996). Cited for: ENZYME REGULATION, PHOSPHORYLATION AT SER-12; SER-13 AND THR-200, ANDMUTAGENESIS OF SER-12 AND SER-13. | |
"Regulation of calcium/calmodulin-dependent kinase IV by O-GlcNAcmodification."; Dias W.B., Cheung W.D., Wang Z., Hart G.W.; J. Biol. Chem. 284:21327-21337(2009). Cited for: GLYCOSYLATION AT THR-57 SER-58; SER-137; SER-189; SER-344; SER-345 ANDSER-356, PHOSPHORYLATION AT THR-200, IDENTIFICATION BY MASSSPECTROMETRY, AND MUTAGENESIS OF 57-THR-SER-58 AND SER-189. | |
"Regulation and function of the calcium/calmodulin-dependent proteinkinase IV/protein serine/threonine phosphatase 2A signaling complex."; Anderson K.A., Noeldner P.K., Reece K., Wadzinski B.E., Means A.R.; J. Biol. Chem. 279:31708-31716(2004). Cited for: ENZYME REGULATION, INTERACTION WITH PROTEIN PHOSPHATASE 2A,PHOSPHORYLATION AT THR-200, AND MUTAGENESIS OF 320-PHE-ASN-321. |